📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

DaShenLin Pharmaceutical Group Co Ltd

Common Name
DaShenLin Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
43,532
Ticker
603233
Exchange
SHANGHAI STOCK EXCHANGE
Description
Dashenlin Pharmaceutical Group Co., Ltd. is a leading company in the pharmaceutical industry, primarily engaged in the retail and wholesale distribution of medicine and healthcare products across Chin...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

DaShenLin Pharmaceutical Group's GHG Emissions Data Preview

In 2024, DaShenLin Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, DaShenLin Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=603233&reporting_period=2024"

Verified Sources Behind DaShenLin Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore DaShenLin Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. DaShenLin Pharmaceutical Group's ESG Report 2024
a. DaShenLin Pharmaceutical Group's ESG Report 2024

Insights into DaShenLin Pharmaceutical Group's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions ofDaShenLin Pharmaceutical Group amounted to19,303.07metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

DaShenLin Pharmaceutical Group's Scope 1 Emissions Over Time

202401.5 k3 k4.5 k6 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are DaShenLin Pharmaceutical Group's Scope 1 emissions?

In 2024, the total Scope 1 emissions of DaShenLin Pharmaceutical Group were 5,220.48 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

What are DaShenLin Pharmaceutical Group's Scope 2 emissions?

In 2024, DaShenLin Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 14,082.59 tCOâ‚‚e without specifying the calculation method.a

What methodology does DaShenLin Pharmaceutical Group use for Scope 2 reporting?

In 2024, DaShenLin Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.a

DaShenLin Pharmaceutical Group's Scope 2 Emissions Over Time

202404 k8 k12 k16 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into DaShenLin Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers

In 2024, DaShenLin Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 5,220.48 tCOâ‚‚e and total revenues of USD 3,631 millions. This translates into an emissions intensity of 1.44 tCOâ‚‚e per millions USD.a

DaShenLin Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202001,00010,000Revenues (Millions of USD)AASDAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,779Scope 1 Intensity: 13.80 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MDDDaShenLin Pharmaceutical GroupYear: 2024Scope 1: 5,220 tCO2eRevenue: $M 3,631Scope 1 Intensity: 1.44 tCO2e/$M

How does DaShenLin Pharmaceutical Group's GHG emissions intensity compare to its peers?

In 2024, DaShenLin Pharmaceutical Group reported a Scope 1 emissions intensity of 1.44 tCOâ‚‚e per millions USD. Compared to the peer group median of 9.75, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does DaShenLin Pharmaceutical Group rank on GHG emissions intensity within its industry?

In 2024, DaShenLin Pharmaceutical Group ranked 5 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places DaShenLin Pharmaceutical Group among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to DaShenLin Pharmaceutical Group's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

CStone Pharmaceuticals

Healthcare
Biotechnology
China (Mainland)

Alphamab Oncology

Healthcare
Biotechnology
China (Mainland)

WuXi Biologics (Cayman) Inc

Healthcare
Biotechnology
China (Mainland)

Asymchem Laboratories (Tianjin) Co Ltd

Healthcare
Biotechnology
China (Mainland)

Jacobio Pharmaceuticals Group Co Ltd

Healthcare
Biotechnology
China (Mainland)

Pharmaron Beijing Co Ltd

Healthcare
Biotechnology
China (Mainland)